ÌÇÐÄÊÓÆµ

Sanjeev Ayyangar Vasudevan

Vasudevan

Sanjeev Ayyangar Vasudevan, M.D.

Professor of Surgery

(832) 822-3135

Positions

Professor of Surgery
Division of Pediatric Surgery
ÌÇÐÄÊÓÆµ of Medicine
Attending Surgeon, Pediatric Surgery Service
Texas Children's Hospital
Program Director, General Surgery Residency - Research Track
ÌÇÐÄÊÓÆµ of Medicine

Addresses

Texas Children's Hospital (Clinic)
Clinical Care Center
6701 Fannin Street
Houston, TX, 77030
United States
Phone: (832) 822-3135

Education

Pediatric Surgery Residency from ÌÇÐÄÊÓÆµ Of Medicine
01/2011 - Houston, TX, United States
General Surgery Residency from ÌÇÐÄÊÓÆµ Of Medicine
01/2009 - Houston, TX, United States
M.D. from Emory University School Of Medicine
01/2001 - Atlanta, GA, United States
B.A. from Emory University
01/1997 - Atlanta, GA, United States
B.S. from Emory University
01/1997 - Atlanta, GA, United States

Certifications

Board Certified - Pediatric Surgery
American Board of Surgery
Board Certified - General Surgery
American Board of Surgery

Honors & Awards

Norton Rose Fulbright Faculty Excellence Award for Teaching & Evaluation
ÌÇÐÄÊÓÆµ of Medicine
2020 Top Doctor: Pediatric Surgery
Houstonia Magazine
Michael E. DeBakey Distinguished Service Award
Michael E. DeBakey Department of Surgery

Professional Interests

  • Pediatric surgical oncology
  • Neuroblastoma

Professional Statement

Dr. Sanjeev A. Vasudevan is committed to providing the finest patient-oriented pediatric surgical care with special attention to the surgical needs of children with cancer and the needs of their families. This dedication combines education and training, advanced research, and the development of newer and better treatments and procedures.
Dr. Vasudevan’s laboratory research focuses on the validation of potential therapeutic targets found in pediatric solid tumors and cancer, in particular neuroblastoma. During his postdoctoral training in the Texas Children’s Cancer Center with Drs. Jed G. Nuchtern and Jianhua Yang, Dr. Vasudevan cloned two novel genes, NDSP and DUSP26, which were found to be specifically expressed in neuroblastoma and play critical roles in neuroblastoma tumor growth and chemosensitivity.
Dr. Vasudevan is furthering this work as the principal investigator of a research project that focuses on the function and regulation of both the p53 and MYCN pathways in neuroblastoma. His lab uses techniques such as retroviral-induced shRNA inhibition of protein expression, real-time PCR, chromatin immunoprecipitation, recombinant protein purification, in vitro proliferation and cytotoxicity assays, orthotopic mouse models of neuroblastoma, and in vivo bioluminescence imaging for molecular target validation. Dr. Vasudevan’s lab research hopes to validate multiple targets in order to find novel and less toxic therapeutic agents to improve outcomes in neuroblastoma.

Videos

Selected Publications

  • Vasudevan SA, Shang X, Chang S, Ge N, Diaz-Miron JL, Russell HV, Hicks MJ, Ludwig AD, Wesson CL, Burlingame SM, Kim ES, Khan J, Yang J, Nuchtern JG. " " Mol. Cancer Ther.. 2009 Aug ; 8 (8) : 2478-89.
    Pubmed PMID: .
  • Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES. " " J. Pediatr. Surg.. 2012 Jun ; 47 (6) : 1261-6.
    Pubmed PMID: .
  • Fallon SC, Redell MS, El-Bietar J, Lopez ME, Vasudevan SA, Brandt ML. " " J. Pediatr. Surg.. 2013 Feb ; 48 (2) : 436-40.
    Pubmed PMID: .
  • Wulkan ML, Vasudevan SA. " " J. Pediatr. Surg.. 2001 Aug ; 36 (8) : 1234-6.
    Pubmed PMID: .

Memberships

American Association for Cancer Research
American College of Surgeons
Phi Beta Kappa
Society of University Surgeons

to edit your profile